As of 2025-06-03, the Fair Value of Biocartis Group NV (BCART.BR) is -3.61 EUR. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.29 EUR, the upside of Biocartis Group NV is -1,345.89%.
With the market price of 0.29 EUR and our fair value calculation, Biocartis Group NV (BCART.BR) is not a good investment. Investing in BCART.BR stocks now will result in a potential loss of 1,345.89%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 5Y Avg | |
| Net income | -48.15 | -64.07 | -62.93 | -71.47 | -65.38 | -62.40 |
| YoY growth | -14.76% | -33.05% | 1.77% | -13.57% | 8.52% | -10.22% |
| Market Cap (mil) | 27.24 |
| P/E | |
| Forward P/E |
| EPS | -0.72 |
| Avg earnings growth rate | -10.22% |
| TTM earnings | -67.87 |